Text this: Impact of ixazomib-lenalidomide-dexamethasone therapy on overall survival in multiple myeloma patients: Analysis of the emerging-markets subgroup of the TOURMALINE-MM1 trial.

 _    _     _____     ______    ______  __    __  
| || | ||  |  ___||  /_   _//  /_   _// \ \\ / // 
| || | ||  | ||__    `-| |,-    -| ||-   \ \/ //  
| \\_/ ||  | ||__      | ||     _| ||_    \  //   
 \____//   |_____||    |_||    /_____//    \//    
  `---`    `-----`     `-`'    `-----`      `